Friday, July 12, 2013

British Journal of Cancer - Table of Contents alert Volume 109 Issue 1

British Journal of Cancer

TABLE OF CONTENTS

Volume 109, Issue 1 (1-296)
Published online 9 July 2013

In this issue
Minireview
Clinical Studies
Translational Therapeutics
Molecular Diagnostics
Epidemiology
Corrigendum

Also new today
Advance online publication

Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
Advertisement
With a new Impact Factor of 5.082*, BJC has maintained the position of 8th most cited cancer title!

Thank you to all our authors, readers, editors, and reviewers.

Check out these top cited BJC papers: 

Guidelines for the welfare and use of animals in cancer research 
 
Circulating microRNAs in plasma of patients with gastric cancers 

Minireview

Top

Cancer chemoprevention: a rapidly evolving field

W P Steward and K Brown

Br J Cancer 2013 109: 1-7; advance online publication, June 4, 2013; 10.1038/bjc.2013.280

Abstract | Full Text

Clinical Studies

Top

Q-TWiST analysis comparing ipilimumab/dacarbazine vs placebo/dacarbazine for patients with stage III/IV melanoma

B Sherrill, J Wang, S Kotapati and K Chin

Br J Cancer 2013 109: 8-13; advance online publication, June 20, 2013; 10.1038/bjc.2013.298

Abstract | Full Text

Asparagine synthetase is an independent predictor of surgical survival and a potential therapeutic target in hepatocellular carcinoma

B Zhang, L-W Dong, Y-X Tan, J Zhang, Y-F Pan, C Yang, M-H Li, Z-W Ding, L-J Liu, T-Y Jiang, J-H Yang and H-Y Wang

Br J Cancer 2013 109: 14-23; advance online publication, June 13, 2013; 10.1038/bjc.2013.293

Abstract | Full Text

Comparison of the prognostic value of longitudinal measurements of systemic inflammation in patients undergoing curative resection of colorectal cancer

G J K Guthrie, C S D Roxburgh, O M Farhan-Alanie, P G Horgan and D C McMillan

Br J Cancer 2013 109: 24-28; advance online publication, June 25, 2013; 10.1038/bjc.2013.330

Abstract | Full Text

Long-term follow-up is crucial after treatment for granulosa cell tumours of the ovary

G Mangili, J Ottolina, A Gadducci, G Giorda, E Breda, A Savarese, M Candiani, L Frigerio, G Scarfone, S Pignata, R Rossi, M Marinaccio and D Lorusso

Br J Cancer 2013 109: 29-34; advance online publication, June 11, 2013; 10.1038/bjc.2013.241

Abstract | Full Text

Characteristics and screening history of women diagnosed with cervical cancer aged 20–29 years

A Castanon, V M W Leung, R Landy, A W W Lim and P Sasieni

Br J Cancer 2013 109: 35-41; advance online publication, July 2, 2013; 10.1038/bjc.2013.322

Abstract | Full Text

The association of waiting times from diagnosis to surgery with survival in women with localised breast cancer in England

M T Redaniel, R M Martin, S Cawthorn, J Wade and M Jeffreys

Br J Cancer 2013 109: 42-49; advance online publication, June 25, 2013; 10.1038/bjc.2013.317

Abstract | Full Text

Hypoxia regulates FGFR3 expression via HIF-1α and miR-100 and contributes to cell survival in non-muscle invasive bladder cancer

C Blick, A Ramachandran, S Wigfield, R McCormick, A Jubb, F M Buffa, H Turley, M A Knowles, D Cranston, J Catto and A L Harris

Br J Cancer 2013 109: 50-59; advance online publication, June 18, 2013; 10.1038/bjc.2013.240

Abstract | Full Text

Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors

P M Willemse, J Burggraaf, N A T Hamdy, N I Weijl, C Y Vossen, L van Wulften, A Q M J van Steijn-van Tol, F R Rosendaal and S Osanto

Br J Cancer 2013 109: 60-67; advance online publication, May 9, 2013; 10.1038/bjc.2013.226

Abstract | Full Text

Translational Therapeutics

Top

Association between ERCC1 and XPA expression and polymorphisms and the response to cisplatin in testicular germ cell tumours

J Mendoza, J Martínez, C Hernández, D Pérez-Montiel, C Castro, E Fabián-Morales, M Santibáñez, R González-Barrios, J Díaz-Chávez, M A Andonegui, N Reynoso, L F Oñate, M A Jiménez, M Núñez, R Dyer and L A Herrera

Br J Cancer 2013 109: 68-75; advance online publication, June 27, 2013; 10.1038/bjc.2013.303

Abstract | Full Text

IRF-1 responsiveness to IFN-γ predicts different cancer immune phenotypes

D Murtas, D Maric, V De Giorgi, J Reinboth, A Worschech, P Fetsch, A Filie, M L Ascierto, D Bedognetti, Q Liu, L Uccellini, L Chouchane, E Wang, F M Marincola and S Tomei

Br J Cancer 2013 109: 76-82; advance online publication, June 27, 2013; 10.1038/bjc.2013.335

Abstract | Full Text

Inhibition of VEGF expression through blockade of Hif1α and STAT3 signalling mediates the anti-angiogenic effect of melatonin in HepG2 liver cancer cells

S Carbajo-Pescador, R Ordoñez, M Benet, R Jover, A García-Palomo, J L Mauriz and J González-Gallego

Br J Cancer 2013 109: 83-91; advance online publication, June 11, 2013; 10.1038/bjc.2013.285

Abstract | Full Text

miR-375 is upregulated in acquired paclitaxel resistance in cervical cancer

Y Shen, P Wang, Y Li, F Ye, F Wang, X Wan, X Cheng, W Lu and X Xie

Br J Cancer 2013 109: 92-99; advance online publication, June 18, 2013; 10.1038/bjc.2013.308

Abstract | Full Text

Intratumoral concentration of estrogens and clinicopathological changes in ductal carcinoma in situ following aromatase inhibitor letrozole treatment

K Takagi, T Ishida, Y Miki, H Hirakawa, Y Kakugawa, G Amano, A Ebata, N Mori, Y Nakamura, M Watanabe, M Amari, N Ohuchi, H Sasano and T Suzuki

Br J Cancer 2013 109: 100-108; advance online publication, June 11, 2013; 10.1038/bjc.2013.284

Abstract | Full Text

Molecular Diagnostics

Top

ALDH1 expression is enriched in breast cancers arising in young women but does not predict outcome

E Y Tan, A A Thike, Breast Surgical Team at Outram2 and P H Tan

Br J Cancer 2013 109: 109-113; advance online publication, June 20, 2013; 10.1038/bjc.2013.297

Abstract | Full Text

Epithelial expression of FHL2 is negatively associated with metastasis-free and overall survival in colorectal cancer

L Verset, J Tommelein, X Moles Lopez, C Decaestecker, M Mareel, M Bracke, I Salmon, O De Wever and P Demetter

Br J Cancer 2013 109: 114-120; advance online publication, June 11, 2013; 10.1038/bjc.2013.290

Abstract | Full Text

Biochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The TUGAMO study

A Alcaraz, R González-López, J Morote, C de la Piedra, C Meseguer, E Esteban, M Climent, B González-Gragera, J-L Álvarez-Ossorio, I Chirivella, B Mellado, P-C Lara, F Vázquez, J-A Contreras, J Carles, A Murias, V Calderero, J Comet-Batlle, A González-del Alba, L León-Mateos, A Mañas, J Segarra, A Lassa, C González-Enguita, M-J Méndez, P Samper, M Unda, I Mahillo-Fernández, J Bellmunt and TUGAMO GROUP

Br J Cancer 2013 109: 121-130; advance online publication, June 25, 2013; 10.1038/bjc.2013.272

Abstract | Full Text

Circulating IL-6 concentrations link tumour necrosis and systemic and local inflammatory responses in patients undergoing resection for colorectal cancer

G J K Guthrie, C S D Roxburgh, C H Richards, P G Horgan and D C McMillan

Br J Cancer 2013 109: 131-137; advance online publication, June 11, 2013; 10.1038/bjc.2013.291

Abstract | Full Text

Both STAT1 and STAT3 are favourable prognostic determinants in colorectal carcinoma

C Gordziel, J Bratsch, R Moriggl, T Knösel and K Friedrich

Br J Cancer 2013 109: 138-146; advance online publication, June 11, 2013; 10.1038/bjc.2013.274

Abstract | Full Text

Markers of systemic inflammation predict survival in patients with advanced renal cell cancer

P Fox, M Hudson, C Brown, S Lord, V Gebski, P De Souza and C K Lee

Br J Cancer 2013 109: 147-153; advance online publication, June 18, 2013; 10.1038/bjc.2013.300

Abstract | Full Text

Tumour morphology predicts PALB2 germline mutation status

Z L Teo, E Provenzano, G S Dite, D J Park, C Apicella, S D Sawyer, P A James, G Mitchell, A H Trainer, G J Lindeman, K Shackleton, L Cicciarelli, kConFab9, S S Buys, I L Andrulis, A M Mulligan, G Glendon, E M John, M B Terry, M Daly, F A Odefrey, T Nguyen-Dumont, G G Giles, J G Dowty, I Winship, D E Goldgar, J L Hopper and M C Southey

Br J Cancer 2013 109: 154-163; advance online publication, June 20, 2013; 10.1038/bjc.2013.295

Abstract | Full Text

Autophagy inhibition induces enhanced proapoptotic effects of ZD6474 in glioblastoma

J Shen, H Zheng, J Ruan, W Fang, A Li, G Tian, X Niu, S Luo and P Zhao

Br J Cancer 2013 109: 164-171; advance online publication, June 25, 2013; 10.1038/bjc.2013.306

Abstract | Full Text

Biological evidence for a causal role of HPV16 in a small fraction of laryngeal squamous cell carcinoma

G Halec, D Holzinger, M Schmitt, C Flechtenmacher, G Dyckhoff, B Lloveras, D Höfler, F X Bosch and M Pawlita

Br J Cancer 2013 109: 172-183; advance online publication, June 18, 2013; 10.1038/bjc.2013.296

Abstract | Full Text

Epithelial-mesenchymal transition-like events in vulvar cancer and its relation with HPV

I S Rodrigues, A M Lavorato-Rocha, B de M Maia, M M A Stiepcich, F M de Carvalho, G Baiocchi, F A Soares and R M Rocha

Br J Cancer 2013 109: 184-194; advance online publication, June 18, 2013; 10.1038/bjc.2013.273

Abstract | Full Text

Membrane expression of MRP-1, but not MRP-1 splicing or Pgp expression, predicts survival in patients with ESFT

E Roundhill and S Burchill

Br J Cancer 2013 109: 195-206; advance online publication, June 25, 2013; 10.1038/bjc.2013.168

Abstract | Full Text

Inhibition of TGF-β and EGF pathway gene expression and migration of oral carcinoma cells by mucosa-associated lymphoid tissue 1

Y Ohyama, Y Kawamoto, T Chiba, G Maeda, H Sakashita and K Imai

Br J Cancer 2013 109: 207-214; advance online publication, June 18, 2013; 10.1038/bjc.2013.307

Abstract | Full Text

Epidemiology

Top

Does thyroid-stimulating hormone influence the prognosis of patients with endometrial cancer? A multicentre trial

V Seebacher, G Hofstetter, S Polterauer, A Reinthaller, C Grimm, R Schwameis, S Taucher, A Wagener, C Marth and N Concin

Br J Cancer 2013 109: 215-218; advance online publication, June 13, 2013; 10.1038/bjc.2013.282

Abstract | Full Text

Cancer prevalence in United States, Nordic Countries, Italy, Australia, and France: an analysis of geographic variability

E Crocetti, R De Angelis, C Buzzoni, A Mariotto, H Storm, M Colonna, R Zanetti, D Serraino, M Michiara, C Cirilli, A Iannelli, G Mazzoleni, O Sechi, M E Sanoja Gonzalez, S Guzzinati, R Capocaccia, L Dal Maso and AIRTUM Working group

Br J Cancer 2013 109: 219-228; advance online publication, June 25, 2013; 10.1038/bjc.2013.311

Abstract | Full Text

Association between tuberculosis infections and non-pulmonary malignancies: a nationwide population-based study

S-C Kuo, Y-W Hu, C-J Liu, Y-T Lee, Y-T Chen, T-L Chen, T-J Chen and C-P Fung

Br J Cancer 2013 109: 229-234; advance online publication, May 7, 2013; 10.1038/bjc.2013.220

Abstract | Full Text

Geography of non-melanoma skin cancer and ecological associations with environmental risk factors in England

B W Wheeler, G Kothencz and A S Pollard

Br J Cancer 2013 109: 235-241; advance online publication, June 11, 2013; 10.1038/bjc.2013.288

Abstract | Full Text

Trends in breast biopsies for abnormalities detected at screening mammography: a population-based study in the Netherlands

V van Breest Smallenburg, J Nederend, A C Voogd, J W W Coebergh, M van Beek, F H Jansen, W J Louwman and L E M Duijm

Br J Cancer 2013 109: 242-248; advance online publication, May 21, 2013; 10.1038/bjc.2013.253

Abstract | Full Text

The impact of aspirin, statins and ACE-inhibitors on the presentation of colorectal neoplasia in a colorectal cancer screening programme

D Mansouri, D C McMillan, C S D Roxburgh, E M Crighton and P G Horgan

Br J Cancer 2013 109: 249-256; advance online publication, June 18, 2013; 10.1038/bjc.2013.292

Abstract | Full Text

Vitamin C intake and breast cancer mortality in a cohort of Swedish women

H R Harris, L Bergkvist and A Wolk

Br J Cancer 2013 109: 257-264; advance online publication, June 4, 2013; 10.1038/bjc.2013.269

Abstract | Full Text

The impact of comorbidity and stage on prognosis of Danish melanoma patients, 1987–2009: a registry-based cohort study

A F Grann, T Frøslev, A B Olesen, H Schmidt and T L Lash

Br J Cancer 2013 109: 265-271; advance online publication, May 16, 2013; 10.1038/bjc.2013.246

Abstract | Full Text

Age remains the major predictor of curative treatment non-receipt for localised prostate cancer: a population-based study

M de Camargo Cancela, H Comber and L Sharp

Br J Cancer 2013 109: 272-279; advance online publication, May 30, 2013; 10.1038/bjc.2013.268

Abstract | Full Text

Risk of lymphoma subtypes after solid organ transplantation in the United States

C A Clarke, L M Morton, C Lynch, R M Pfeiffer, E C Hall, T M Gibson, D D Weisenburger, O Martínez-Maza, S K Hussain, J Yang, E T Chang and E A Engels

Br J Cancer 2013 109: 280-288; advance online publication, June 11, 2013; 10.1038/bjc.2013.294

Abstract | Full Text

Body mass index and the risk of meningioma, glioma and schwannoma in a large prospective cohort study (The HUNT Study)

M Wiedmann, C Brunborg, K Lindemann, T B Johannesen, L Vatten, E Helseth and J A Zwart

Br J Cancer 2013 109: 289-294; advance online publication, June 18, 2013; 10.1038/bjc.2013.304

Abstract | Full Text

Corrigendum

Top

Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors

P M Willemse, J Burggraaf, N A T Hamdy, N I Weijl, C Y Vossen, L van Wulften, A Q M J van Steijn-van Tol, F R Rosendaal and S Osanto

Br J Cancer 2013 109: 295-296; 10.1038/bjc.2013.358

Full Text

Advertisement
Hot off the press!!

Read this recent study published in British Journal of Cancer
The benefits and harms of breast cancer screening: an independent review

Like what you see? Spread the word. [Twitter]  [Facebook]

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: